AFP Detects Liver Cancer in Patients Without HCV

Share this content:
AFP Detects Liver Cancer in Patients Without HCV
AFP Detects Liver Cancer in Patients Without HCV

(HealthDay News) -- Measurement of α-fetoprotein (AFP) detects hepatocellular carcinoma (HCC) most accurately in patients without hepatitis C virus (HCV) infection, according to a study published in the May issue of Clinical Gastroenterology and Hepatology.

Purva Gopal, MD, from the University of Texas Southwestern Medical Center in Dallas, and colleagues analyzed data from patients with cirrhosis (with [452 patients] or without [676 patients] HCC) from January 2005 through June 2012. Levels of AFP were calculated that would detect HCC with the highest levels of sensitivity and specificity in subgroups using receiver operator characteristic analysis.

RELATED: Gastrointestinal Cancers Resource Center

The researchers found that levels of AFP >20 ng/mL detected HCC with 70.1% sensitivity and 89.8% specificity. Patients with HCC were identified with this AFP level with a c-statistic of 0.87, but it was significantly more accurate in HCV-negative patients than in HCV-positive patients (P = 0.007). 

HCC in patients with HCV-associated cirrhosis was most accurately detected with AFP levels ≥59 ng/mL, while levels of AFP ≥11 ng/mL accurately identified HCC in HCV-negative patients.

"Based on a retrospective analysis of data from patients with cirrhosis, with or without HCC, AFP level most accurately detects HCC in patients without HCV infection," the researchers wrote.

Reference

  1. Gopal P, Yopp AC, Waljee AK, et al. Factors That Affect Accuracy of α-Fetoprotein Test in Detection of Hepatocellular Carcinoma in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2014;12(5):870-877.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs